More than ten percent of relapses occur after five years in AML patients with NPM1 mutation-Reference-Cited by-同舟云学术

More than ten percent of relapses occur after five years in AML patients with NPM1 mutation

Published:2020-02-05 Issue:5 Volume:61 Page:1226-1229
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Bertoli Sarah¹²³,Tavitian Suzanne¹,Bérard Emilie⁴⁵,Mansat-De Mas Véronique²³⁶,Largeaud Laetitia²⁶,Gadaud Noémie¹,Rieu Jean-Baptiste⁶,Vergez François²³⁶,Luquet Isabelle⁶,Huguet Françoise¹,Sarry Audrey¹,Delabesse Eric²³⁶,Récher Christian¹²³

Affiliation:

1. Service d'Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France;

2. Université Toulouse III Paul Sabatier, Toulouse, France;

3. Cancer Research Center of Toulouse, UMR1037-INSERM, ERL5294 CNRS, Toulouse, France;

4. Service d’Epidémiologie, Centre Hospitalier Universitaire de Toulouse, Toulouse, France;

5. UMR 1027, INSERM-Université de Toulouse III, Toulouse, France;

6. Laboratoire d’Hématologie, Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire de Toulouse, Toulouse, France

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2019.1706733

Reference14 articles.

1. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

2. Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years)

3. Late relapses in acute myeloid leukemia: analysis of characteristics and outcome

4. Younger adults with acute myeloid leukemia in remission for ≥3 years have a high likelihood of cure: The ECOG experience in over 1200 patients

5. Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relapse of NPM1-Mutated AML with Extramedullary Manifestation 17 Years after Allogeneic Hematopoietic Stem Cell Transplantation;Case Reports in Hematology;2022-12-28

2. Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes;Proceedings of the National Academy of Sciences;2021-11-29

3. The Role of NPM1 in the Invasion and Migration of Drug Resistant Bladder Cancer;UROL J;2021

4. Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field;Leukemia;2021-04-20

5. Late and very late relapses in acute myeloid leukemia (AML);Leukemia & Lymphoma;2020-04-14